BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

United States, BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

The best Articles in our Network

United Kingdom

Addionics from London secures $39M to boost EV Battery Performance with innovative 3D Technology

India

10 Top Startups To Watch In Mumbai, India

United Kingdom

Cohere from Canada raises $500M at $5.5B Valuation

United Kingdom

Deepc from Germany bags €11.9M to enhance AI Radiology Platform

United Kingdom

Lakera from Switzerland raises $20M to protect Enterprises from AI Vulnerabilities

United Kingdom

Top San Francisco Startups to Watch in 2024

Previous

Next